Baiyunshan proposes $90m dividend, plans mid-year cash distribution

** Guangzhou Baiyunshan Pharmaceutical Holdings will seek shareholder approval for a 2024 dividend payout of RMB 650.3 million (approximately $90 million USD), equating to RMB 0.40 per share, at its upcoming annual general meeting. The proposal follows the company's reported RMB 2.835 billion in net profits and was informed by China Securities Regulatory Commission guidelines to enhance shareholder returns. Additionally, the company disclosed plans for a mid-year cash dividend in 2025, not to exceed a yet-to-be determined amount. The company also announced the appointment of auditors and that the Company intends to comply with all financial reporting requirements.